International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 7062 - 7062
Published: June 27, 2024
In
inflammatory
bowel
diseases
(IBDs),
such
as
Crohn's
disease
(CD)
and
ulcerative
colitis
(UC),
the
immune
system
relentlessly
attacks
intestinal
cells,
causing
recurrent
tissue
damage
over
lifetime
of
patients.
The
etiology
IBD
is
complex
multifactorial,
involving
environmental,
microbiota,
genetic,
immunological
factors
that
alter
molecular
basis
organism.
Among
these,
microbiota
cells
play
pivotal
roles;
generates
antigens
recognized
by
antibodies,
while
autoantibodies
target
attack
membrane,
exacerbating
inflammation
damage.
Given
altered
framework,
analysis
multiple
biomarkers
in
patients
proves
exceedingly
valuable
for
diagnosing
prognosing
IBD,
including
markers
like
C
reactive
protein
fecal
calprotectin.
Upon
detection
classification
patients,
specific
treatments
are
administered,
ranging
from
conventional
drugs
to
new
biological
therapies,
antibodies
neutralize
molecules
tumor
necrosis
factor
(TNF)
integrin.
This
review
delves
into
targets,
biomarkers,
treatment
options,
monitoring
techniques,
and,
ultimately,
current
challenges
management.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
164, P. 114985 - 114985
Published: June 11, 2023
The
gut
microbiota
is
indispensable
for
maintaining
host
health
by
enhancing
the
host's
digestive
capacity,
safeguarding
intestinal
epithelial
barrier,
and
preventing
pathogen
invasion.
Additionally,
exhibits
a
bidirectional
interaction
with
immune
system
promotes
of
to
mature.
Dysbiosis
microbiota,
primarily
caused
factors
such
as
genetic
susceptibility,
age,
BMI,
diet,
drug
abuse,
significant
contributor
inflammatory
diseases.
However,
mechanisms
underlying
diseases
resulting
from
dysbiosis
lack
systematic
categorization.
In
this
study,
we
summarize
normal
physiological
functions
symbiotic
in
healthy
state
demonstrate
that
when
occurs
due
various
external
factors,
are
lost,
leading
pathological
damage
lining,
metabolic
disorders,
barrier
damage.
This,
turn,
triggers
disorders
eventually
causes
systems.
These
discoveries
provide
fresh
perspectives
on
how
diagnose
treat
unrecognized
variables
might
affect
link
between
illnesses
need
further
studies
extensive
basic
clinical
research
will
still
be
required
investigate
relationship
future.
Gut,
Journal Year:
2022,
Volume and Issue:
71(12), P. 2574 - 2586
Published: Sept. 16, 2022
The
diet
and
gut
microbiota
have
been
extensively
interrogated
as
a
fuel
for
inflammation
in
inflammatory
bowel
diseases
(IBDs)
the
last
few
years.
Here,
we
review
how
specific
nutrients,
typically
enriched
Western
diet,
instigate
or
deteriorate
experimental
genetically
susceptible
host
discuss
microbiota-dependent
independent
mechanisms.
We
depict
study
landscape
of
nutritional
trials
paediatric
adult
IBD
delineate
common
grounds
dietary
advice.
Conclusively,
reflects
critical
rheostat
microbial
dysbiosis
IBD.
Dietary
restriction
by
exclusive
enteral
nutrition,
with
without
exclusion
is
effectively
treating
Crohn’s
disease,
while
are
less
conclusive.
Insights
into
molecular
mechanisms
therapy
will
change
perception
allow
us
to
enter
era
precision
nutrition.
To
achieve
this,
need
carefully
designed
scientific
rigour
comparable
medical
trials,
which
also
requires
action
from
stake
holders.
Establishing
evidence-based
does
not
only
hold
promise
avoid
long-term
immunosuppression,
but
provide
widely
accessible
at
low
cost.
Identification
culprits
disturbing
health
bears
potential
prevent
allows
informed
decision
making
food
politics.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: April 5, 2022
Diet
is
an
important
lifestyle
factor
that
known
to
contribute
in
the
development
of
human
disease.
It
well
established
poor
diet
plays
active
role
exacerbating
metabolic
diseases,
such
as
obesity,
diabetes
and
hypertension.
Our
understanding
how
immune
system
drives
chronic
inflammation
disease
pathogenesis
has
evolved
recent
years.
However,
contribution
dietary
factors
inflammatory
conditions
bowel
disease,
multiple
sclerosis
arthritis
remain
poorly
defined.
A
western
been
associated
pro-inflammatory,
contrast
traditional
patterns
are
being
anti-inflammatory.
This
may
be
due
direct
effects
nutrients
on
cell
function.
also
affect
composition
function
gut
microbiota,
which
consequently
affects
immunity.
In
animal
models
modulate
gastrointestinal
tract
other
peripheral
sites.
Despite
limitations
models,
there
now
emerging
evidence
show
anti-inflammatory
translate
diseases.
appropriately
designed,
larger
clinical
studies
must
conducted
confirm
therapeutic
benefit
therapy.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(14), P. 2970 - 2970
Published: July 20, 2022
Psoriasis
is
a
chronic
inflammatory
skin
disease
with
autoimmune
pathogenic
characteristics
and
caused
by
inflammation,
which
results
in
uncontrolled
keratinocyte
growth
defective
differentiation.
The
link
between
the
gut
microbiota
immune
system
regulation
opened
novel
angle
to
understand
pathogenesis
of
many
multifactorial
diseases,
including
psoriasis.
Current
evidence
suggests
that
modulation
microbiota,
both
through
dietary
approaches
supplementation
probiotics
prebiotics,
could
represent
therapeutic
approach.
present
work
aims
highlight
latest
scientific
regarding
microbiome
alterations
psoriatic
patients,
as
well
state
art
insights
terms
microbiome-targeted
therapies
promising
preventive
tools
for
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(11), P. 9577 - 9577
Published: May 31, 2023
The
human
gut
microbiome
contains
the
largest
number
of
bacteria
in
body
and
has
potential
to
greatly
influence
metabolism,
not
only
locally
but
also
systemically.
There
is
an
established
link
between
a
healthy,
balanced,
diverse
overall
health.
When
becomes
unbalanced
(dysbiosis)
through
dietary
changes,
medication
use,
lifestyle
choices,
environmental
factors,
ageing,
this
profound
effect
on
our
health
linked
many
diseases,
including
metabolic
inflammatory
neurological
diseases.
While
humans
largely
association
dysbiosis
with
disease,
animal
models,
causative
can
be
demonstrated.
brain
particularly
important
maintaining
health,
strong
neurodegenerative
neurodevelopmental
This
suggests
that
microbiota
composition
used
make
early
diagnosis
diseases
modifying
microbiome-gut-brain
axis
might
present
therapeutic
target
for
have
proved
intractable,
aim
altering
trajectory
such
as
Alzheimer's
Parkinson's
multiple
sclerosis,
autism
spectrum
disorder,
attention-deficit
hyperactivity
among
others.
other
potentially
reversible
migraine,
post-operative
cognitive
dysfunction,
long
COVID,
which
considered
models
therapy
disease.
role
traditional
methods
microbiome,
well
newer,
more
novel
treatments
faecal
transplants
photobiomodulation,
are
discussed.